Edwards Lifesciences Corp. (EW)
-NYSE 70.48 
0.48(0.69%) Jun 17, 4:01PM EDT|After Hours
:
70.48 0.00 (0.00%) Jun 17, 4:42PM EDT
| Prev Close: | 70.00 |
|---|
| Open: | 70.38 |
|---|
| Bid: | 69.46 x 100 |
|---|
| Ask: | 71.99 x 100 |
|---|
| 1y Target Est: | 76.94 |
|---|
| Beta: | 0.67 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 70.08 - 70.68 |
|---|
| 52wk Range: | 62.34 - 110.79 |
|---|
| Volume: | 814,585 |
|---|
| Avg Vol (3m): | 1,511,970 |
|---|
| Market Cap: | 7.96B |
|---|
| P/E (ttm): | 22.28 |
|---|
| EPS (ttm): | 3.16 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- German Court Rules in Favor of MDTZacks(Mon, Jun 17)
- InPlay: Edwards Lifesciences: New data on Edwards Perimount valves demonstrate long-term durability in patients aged 60 and younger; the data similarly showed that the perimount valve had an expected durability of more than 16 years in theBriefing.com(Mon, Jun 17)
- New Data on Edwards PERIMOUNT Valves Demonstrate Long-Term Durability in Patients Aged 60 and YoungerMarketwired(Mon, Jun 17)
- Medtronic, `Happy Birthday': Intellectual Propertyat Bloomberg(Mon, Jun 17)
- German Court Rules Against Edward Lifesciences; Stock Falls 3%at Barrons.com(Fri, Jun 14)
- Medtronic Valves Don’t Infringe Edwards German Patentat Bloomberg(Fri, Jun 14)
- The 5 Worst Medical Device Stocks of 2013at Motley Fool(Fri, Jun 14)
- Edwards Q2 commercial implants should beat expectations, says Wells Fargotheflyonthewall.com(Fri, Jun 14)
- Edwards loses patent bid in Germany versus Medtronic, Bloomberg saystheflyonthewall.com(Fri, Jun 14)
- Reasons to Buy These 3 Stocksat Motley Fool(Thu, Jun 13)
- Agree To Buy Edwards Lifesciences At $55, Earn 7.1%at Forbes(Thu, Jun 13)
- Is This Fallen Angel Still a Good Growth Play?at Motley Fool(Tue, Jun 11)
- Mover roundup: Federal-Mogul, Edwards LifesciencesAP(Mon, Jun 10)
- Analysts: Facebook Is Still Overweight Post Sell-Off and 3 More Research Notes to Readat Wall St. Cheat Sheet(Mon, Jun 10)
- Edwards Lowered to UnderperformZacks(Mon, Jun 10)
Key Statistics
| Forward P/E (1 yr): | 19.36 |
|---|
| P/S (ttm): | 4.08 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.05 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.76 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.51 |
|---|
Business Summary
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products,...
View More